Information Disclosure

---

Announcements and Notices – Notice of Annual General Meeting

2020-5-15

View

---

Proxy form for the annual general meeting to be held on 19 June 2020 or any adjournment thereof

2020-5-15

View

---

Circulars – General Mandate to Repurchase Shares and Issue New Shares; Re-Election of Retiring Directors; Re-Appointment of Auditor; and Notice of Annual General Meeting

2020-5-15

View

---

Announcements and Notices – FURTHER ANNOUNCEMENT ON AUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019

2020-5-12

View

---

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2020

2020-5-6

View

---

Announcements and Notices – VOLUNTARY ANNOUNCEMENT: THE GROUP’S WORLD-WIDE INNOVATIVE DRUG STC3141 GOT APPROVAL FOR PHASE II CLINICAL RESEARCH ON COVID-19 ARDS AND PHASE IB CLINICAL RESEARCH ON SEPSIS

2020-5-6

View

---

Announcements and Notices – VOLUNTARY ANNOUNCEMENT: FURTHER SUBSCRIPTION OF SHARES IN AN ASSOCIATED COMPANY

2020-5-5

View

---

Announcements and Notices – VOLUNTARY ANNOUNCEMENT: THE GROUP OBTAINED MEDICAL DEVICE REGISTRATION CERTIFICATE FOR THE FIRST DRUG COATED BALLOON SPECIFIED FOR VASCULAR ACCESS FOR HEMODIALYSIS IN THE PRC MARKET

2020-4-20

View

---

Announcements and Notices – VOLUNTARY ANNOUNCEMENT: THE GROUP OBTAINED THE DEVELOPMENT AND COMMERCIALIZATION RIGHTS OF A NEW DRUG FOR PTERYGIUM

2020-4-14

View

---

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2020

2020-4-3

View

---

Announcements and Notices – ANNOUNCEMENT OF UNAUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019

2020-3-27

View

---

Announcements and Notices – VOLUNTARY ANNOUNCEMENT: THE GROUP OBTAINED THE DEVELOPMENT AND COMMERCIALIZATION RIGHTS OF A WORLD-WIDE FIRST DEVELOPED DRUG FOR SEPSIS

2020-3-22

View

---

Announcements and Notices – DATE OF BOARD MEETING

2020-3-17

View

---

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2020

2020-3-5

View

---

Announcements and Notices – POSITIVE PROFIT ALERT

2020-2-23

View

---

Announcements and Notices – VOLUNTARY ANNOUNCEMENT: COMPLETION OF PURCHASE OF SHARES OF ONCOSEC MEDICAL INCORPORATED AND EFFECTIVENESS OF EXCLUSIVE COMMERCIAL RIGHTS OF THE LICENSED PRODUCTS IN THE LICENSED TERRITORIES

2020-2-9

View

---

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2020

2020-2-6

View

---

Announcements and Notices – VOLUNTARY ANNOUNCEMENT: THE GROUP OBTAINED THE DEVELOPMENT AND COMMERCIALIZATION RIGHTS OF A NEW DRUG FOR DRY EYE SYNDROME AND WILL SUBSCRIBE SHARES IN A TAIWAN COMPANY

2020-1-5

View

---

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2019

2020-1-3

View